TMC6 and infection: The infection was evaluated by immunolabeling the VP1 capsid protein of EV1, which was detected as high levels in the cytoplasm of the control cells, but only showed the input virus in endosomes in vemurafenib-treated cells (Fig. 4C), indicating that the protein production of EV1 was halted.